Ascendis Pharma A/S (ASND)

208.98 -3.83 (-1.80%) USD  |  NASDAQ  |  Dec 26, 16:00
209.98 +1.00 (+0.48%) Pre-Market: 07:59
More

Ascendis Pharma Amortization Expense CF (% of Quarterly Assets)

Amortization Expense CF (% of Quarterly Assets) Chart

View Amortization Expense CF (% of Quarterly Assets) for ASND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years

View Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (% of Quarterly Assets) Benchmarks

View Amortization Expense CF (% of Quarterly Assets) Benchmarks
Start Trial
Novo Nordisk A/S --
Evaxion AS --
DBV Technologies SA --
Cellectis SA --
Akari Therapeutics Plc Upgrade